Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction

NCT: NCT07464275 · COMPLETED

NCT IDNCT07464275
StatusCOMPLETED
Start Date2026-04-22
Completion2026-05-25

Brief Summary

This is a retrospective, observational, single-arm, multi-center study to evaluate the predictive performance of MAGENTA BLAST, an artificial intelligence (AI)-enabled software application, when used as analytical, adjunctive information to support Day 3 cleavage stage embryo predictions of blastocyst formation by Day 5.

Frequently Asked Questions

What is Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction?

Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction is a clinical trial registered under NCT07464275. Current status: COMPLETED.

What is the status of NCT07464275?

The current status of NCT07464275 (Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction) is: COMPLETED.

When did Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction start?

Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction started on 2026-04-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑